Scribe Therapeutics reported a second milestone, achieved with the help of Scribe’s proprietary X-Editor (XE) platform, in its multi-program collaboration with Eli Lilly focused on …
Read More
Terray Therapeutics, a Los Angeles–based biotechnology company developing an AI-driven small-molecule discovery platform, has introduced a new version of its TerraBind potency prediction model within …
Read More
Clinical development is still shaped by a stubborn asymmetry: only around one in ten drug candidates that enter human testing ever reaches approval, and Phase …
Read More
In a collaboration that embeds AI directly into trial design and analysis to reduce statistical and operational risk, Unlearn will deploy patient-level AI-generated digital twins …
Read More
February 11 marks the UN-designated International Day of Women and Girls in Science, established by the General Assembly in December 2015 to recognize the contributions …
Read More
On the heels of Johnson & Johnson multi-modality drug discovery collaboration last month, Isomorphic Labs has now published benchmark results for its unified AI drug …
Read More
